An observational study in Traumatic Brain Injury, sponsored by Joseph D. Tobias. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2017-02-01.
Sponsored by Joseph D. Tobias · Observational
This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.
2,113 studies on the registry are indexed under Brain Injuries; 384 are open to participants now.
This study's enrollment of 38 is below the median of 100 across 689 observational studies indexed under Brain Injuries.
Browse Brain Injuries studies →Joseph D. Tobias is the lead sponsor of 28 studies on the registry; 4 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 6 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients suffering a traumatic brain injury who were sedated in the PICU using remifentanil.
Exclusion Criteria:
Patients sedated using Remifentanil
Drug: Remifentanil
Depth of Sedation
Sedation scores will be assessed.
Time frame: Every 24 hrs until discharged from the PICU, up to 1 month.
This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Joseph D. Tobias